Analysis of the current state of frailty indexes and their implementation for aging intervention studies
Abstract
Animal lifespan studies are foundational to developing interventions against the biological aging process. In recent years, there has been rising interest in characterizing the effects of longevity therapeutics on health span. Frailty indexes, originally developed to assess clinical frailty in aging humans, have shown promise as measurements of biological age and have been adopted for use in rodent aging biology. This perspective looks at the current state of rodent frailty indexes and how they are implemented. The differences in frailty parameters used to calculate these indexes have led to inconsistencies between studies defining frailty. In this perspective, we have highlighted those differences and made recommendations for implementing protocols for frailty index measurement.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper discusses the inconsistencies in frailty indexes used in rodent aging studies and offers recommendations for their implementation. The focus on frailty indexes as a measurement of biological age in the context of aging interventions is pertinent to understanding and potentially mitigating the biological aging process.
Author of this paper? Send a correction.